In this session, Bruce Thompson will breakdown the elections results, project potential leadership, and focus on how the next Congress will impact companies doing business in or with the United States. Panelists, featuring Lowenstein's Doreen M....
Lowenstein represented ZyVersa Therapeutics, Inc. (“ZyVersa"), a clinical stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop products for patients with renal or inflammatory diseases with high unmet m...
This panel, featuring Lowenstein's Brent Weisenberg, will discuss mediation in mass tort/multi-party cases such as Puerto Rico, Purdue, Boy Scouts and the various religious institutions that have filed for bankruptcy. Topics to include (a) mediati...
SEC Must Set Due Diligence Standards for Use of Alternative Data
The alternative data market allows investors to access hyper-detailed information about commercial activity, supplementing traditional financial analysis. Steady demand from investors for this cutting-edge data has rapidly expanded its market. Alt...